Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

NV 5138

Drug Profile

NV 5138

Alternative Names: NV-5138

Latest Information Update: 17 Sep 2019

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Navitor Pharmaceuticals; X-Chem
  • Developer Navitor Pharmaceuticals
  • Class Antidepressants; Small molecules
  • Mechanism of Action MTORC1 protein stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase I Depressive disorders

Most Recent Events

  • 13 Sep 2019 Efficacy, adverse events and pharmacokinetics data from a phase-I programme in Depressive disorders (Treatment-resistant) and healthy volunteers released by Navitor Pharmaceuticals
  • 15 Jul 2019 Navitor Pharmaceuticals has patent protection for NV 5138
  • 07 Jul 2019 Navitor Pharmaceuticals completes a phase I trial in Depressive disorders (In volunteers, Treatment-resistant) in USA (NCT03606395)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top